1,022
Views
1
CrossRef citations to date
0
Altmetric
Articles

Prevalence of Trachoma and Access to Water and Sanitation in Benue State, Nigeria: Results of 23 Population-Based Prevalence Surveys

, , , , , , , , , , , , , , & show all
Pages 79-85 | Received 13 Jan 2018, Accepted 13 Apr 2018, Published online: 31 Dec 2018

References

  • Bourne RR, Stevens GA, White RA, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Global Health. 2013;1(6):e339–49. doi:10.1016/S2214-109X(13)70113-X.
  • Gambhir M, Basanez MG, Burton MJ, et al. The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control. PLoS Negl Trop Dis. 2009;3(6):e462. doi:10.1371/journal.pntd.0000462.
  • Emerson PM Ecology and control of the trachoma vector Musca sorbens [available at http://etheses.dur.ac.uk/3995/; downloaded 13 July 2012 [Doctor of Philosophy thesis]. Durham: University of Durham; 2001.
  • Smith JL, Flueckiger RM, Hooper PJ, et al. The geographical distribution and burden of trachoma in Africa. PLoS Negl Trop Dis. 2013;7(8):e2359. doi:10.1371/journal.pntd.0002359.
  • World Health Organization. WHO Alliance for the Global Elimination of Trachoma by 2020: progress report on elimination of trachoma, 2014-2016. Wkly Epidemiol Rec. 2017;92(26):359–368.
  • Smith JL, Sivasubramaniam S, Rabiu MM, Kyari F, Solomon AW, Gilbert C. Multilevel analysis of trachomatous trichiasis and corneal opacity in Nigeria: the role of environmental and climatic risk factors on the distribution of disease. PLoS Negl Trop Dis. 2015;9(7):e0003826. doi:10.1371/journal.pntd.0003826.
  • World Health Organization. Planning for the Global Elimination of Trachoma (GET): Report of a WHO Consultation, Geneva, Switzerland, 25 & 26 November 1996 (WHO/PBL/97.60). Geneva: World Health Organization; 1997.
  • World Health Assembly. Global Elimination of Blinding Trachoma. 51st World Health Assembly, Geneva, 16 May 1998, Resolution WHA51.11. Geneva: World Health Organization; 1998.
  • Solomon AW, Zondervan M, Kuper H, Buchan JC, Mabey DCW, Foster A. Trachoma Control: A Guide for Programme Managers. Geneva: World Health Organization; 2006.
  • World Health Organization. Validation of Elimination of Trachoma as a Public Health Problem (WHO/HTM/NTD/2016.8). Geneva: World Health Organization; 2016.
  • Solomon AW, Kurylo E. The global trachoma mapping project. Community Eye Health. 2014;27(85):18.
  • Smith JL, Haddad D, Polack S, et al. Mapping the global distribution of trachoma: why an updated atlas is needed. PLoS Negl Trop Dis. 2011;5(6):e973. doi:10.1371/journal.pntd.0000973.
  • King JD, Jip N, Jugu YS, et al. Mapping trachoma in Nasarawa and Plateau States, central Nigeria. Br J Ophthalmol. 2010;94(1):14–19. doi:10.1136/bjo.2009.165282.
  • Muhammad N, Mohammed A, Isiyaku S, Adamu MD, Gwom A, Rabiu MM. Mapping trachoma in 25 local government areas of Sokoto and Kebbi states, northwestern Nigeria. Br J Ophthalmol. 2014;98(4):432–437. doi:10.1136/bjophthalmol-2013-303703.
  • Adamu MD, Mpyet C, Muhammad N, et al. Prevalence of Trachoma in Niger State, North Central Nigeria: results of 25 population-based prevalence surveys carried out with the global trachoma mapping project. Ophthalmic Epidemiol. 2016;23(Sup 1):63–69. doi:10.1080/09286586.2016.1242757.
  • Alada JJ, Mpyet C, Florea VV, et al. Prevalence of Trachoma in Kogi State, Nigeria: results of four local government area-level surveys from the global trachoma mapping project. Ophthalmic Epidemiol. 2018;25(Sup 1):33–40. doi.org/10.1080/09286586.2017.1409359.
  • Jip NF, King JD, Diallo MO, et al. Blinding trachoma in Katsina state, Nigeria: population-based prevalence survey in ten local government areas. Ophthalmic Epidemiol. 2008;15(5):294–302. doi:10.1080/09286580802256542.
  • Mpyet C, Muhammad N, Mohammed AD, et al. Prevalence of trachoma in Kano State, Nigeria: results of 44 Local Government Area-level surveys. Ophthalmic Epidemiol. 2017;24(3):195–203. doi:10.1080/09286586.2016.1265657.
  • Mpyet C, Muhammad N, Adamu MD, et al. Prevalence of trachoma in Katsina State, Nigeria: results of 34 district-level surveys. Ophthalmic Epidemiol. 2016;23(Sup 1):55–62. doi:10.1080/09286586.2016.1236975.
  • Mpyet C, Muhammad N, Adamu MD, et al. Prevalence of trachoma in Bauchi State, Nigeria: results of 20 local government area-level surveys. Ophthalmic Epidemiol. 2016;23(Sup 1):39–45. doi:10.1080/09286586.2016.1238945.
  • Mpyet C, Muhammad N, Adamu MD, et al. Trachoma mapping in Gombe State, Nigeria: results of 11 local government area surveys. Ophthalmic Epidemiol. 2016;23(6):406–411. doi:10.1080/09286586.2016.1230633.
  • Mpyet C, Ogoshi C, Goyol M. Prevalence of trachoma in Yobe State, north-eastern Nigeria. Ophthalmic Epidemiol. 2008;15(5):303–307. doi:10.1080/09286580802237633.
  • Muhammad N, Mpyet C, Adamu MD, et al. Mapping Trachoma in Kaduna State, Nigeria: results of 23 local government area-level, population-based prevalence surveys. Ophthalmic Epidemiol. 2016;23(Sup 1):46–54. doi:10.1080/09286586.2016.1250918.
  • Ramyil A, Wade P, Ogoshi C, et al. Prevalence of trachoma in Jigawa State, north-western Nigeria. Ophthalmic Epidemiol. 2015;22(3):184–189. doi:10.3109/09286586.2015.1037399.
  • Mpyet C, Lass BD, Yahaya HB, Solomon AW. Prevalence of and risk factors for trachoma in Kano state, Nigeria. PLoS One. 2012;7(7):e40421. doi:10.1371/journal.pone.0040421.
  • Solomon AW, Pavluck A, Courtright P, et al. The Global Trachoma Mapping Project: methodology of a 34-country population-based study. Ophthalmic Epidemiol. 2015;22(3):214–225. doi:10.3109/09286586.2015.1037401.
  • National Population Commission. 2006 Population and Housing Census of the Federal Republic of Nigeria: National and State Population and Housing Tables, Priority Tables (Volume 1). Abuja: National Population Commission; 2009.
  • Courtright P, Gass K, Lewallen S, et al. Global Trachoma Mapping Project: Training for Mapping of Trachoma (Version 2) [Available At: Http://Www.Trachomacoalition.Org/Node/357]. London: International Coalition for Trachoma Control; 2013.
  • Grais RF, Rose AM, Guthmann J-P. Don’t spin the pen: two alternative methods for second-stage sampling in urban cluster surveys. Emerg Themes Epidemiol. 2007;4:8. doi:10.1186/1742-7622-4-8.
  • Turner AG, Magnani RJ, Shuaib M. A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) Cluster Survey design. Int J Epidemiol. 1996;25(1):198–203. doi:10.1093/ije/25.1.198.
  • Milligan P, Njie A, Bennett S. Comparison of two cluster sampling methods for health surveys in developing countries. Int J Epidemiol. 2004;33(3):469–476. doi:10.1093/ije/dyh096.
  • World Health Organization, UNICEF. Progress on Sanitation and Drinking Water: 2015 Update and MDG Assessment. Geneva: UNICEF and World Health Organization; 2015.
  • World Health Organization and UNICEF. Core Questions on Drinking-Water and Sanitation for Household Surveys. [Available At: Http://www.wssinfo.org/fileadmin/user_upload/resources/1268174016-JMP_Core_Questions.pdf, Accessed 1 September 2013]. Geneva: World Health Organization/UNICEF; 2006.
  • Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR. A simple system for the assessment of trachoma and its complications. Bull World Health Organ. 1987;65(4):477–483.
  • World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053.
  • Pavluck A, Chu B, Mann Flueckiger R, Ottesen E. Electronic data capture tools for global health programs: evolution of LINKS, an Android-, web-based system. PLoS Negl Trop Dis. 2014;8(4):e2654. doi:10.1371/journal.pntd.0002654.
  • Evans JR, Solomon AW. Antibiotics for trachoma. Cochrane Database Syst Rev. 2011;3:CD001860.
  • Burton M, Habtamu E, Ho D, Gower EW. Interventions for trachoma trichiasis. Cochrane Database Syst Rev. 2015;11:CD004008.
  • Rabiu MM, Abiose A. Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiol. 2001;8(2–3):181–190. doi:10.1076/opep.8.2.181.4167.
  • Mpyet C, Solomon AW. Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria. Br J Ophthalmol. 2005;89(4):417–419. doi:10.1136/bjo.2004.048777.
  • Kalua K, Chisambi A, Chinyanya D, et al. Completion of Baseline Trachoma mapping in Malawi: results of eight population-based prevalence surveys conducted with the global trachoma mapping project. Ophthalmic Epidemiol. 2016;23(Sup 1):32–8. doi:10.1080/09286586.2016.1230224.
  • Bero B, Macleod C, Alemayehu W, et al. Prevalence of and risk factors for trachoma in Oromia regional state of Ethiopia: results of 79 population-based prevalence surveys conducted with the global trachoma mapping project. Ophthalmic Epidemiol. 2016;23(6):392–405. doi:10.1080/09286586.2016.1243717.
  • Elshafie BE, Osman KH, Macleod C, et al. The epidemiology of Trachoma in Darfur States and Khartoum State, Sudan: results of 32 population-based prevalence surveys. Ophthalmic Epidemiol. 2016;23(6):381–391. doi:10.1080/09286586.2016.1243718.
  • Sherief ST, Macleod C, Gigar G, et al. The prevalence of trachoma in Tigray region, Northern Ethiopia: results of 11 population-based prevalence surveys completed as part of the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23(Sup 1):94–99. doi:10.1080/09286586.2016.1250917.
  • Adera TH, Macleod C, Endriyas M, et al. Prevalence of and risk factors for trachoma in Southern Nations, Nationalities, and Peoples’ Region, Ethiopia: results of 40 population-based prevalence surveys carried out with the Global Trachoma Mapping Project. Ophthalmic Epidemiol. 2016;23(Sup 1):84–93. doi:10.1080/09286586.2016.1247876.
  • Desmond N, Solomon AW, Massae PA, et al. Acceptability of azithromycin for the control of trachoma in Northern Tanzania. Trans R Soc Trop Med Hyg. 2005;99(9):656–663. doi:10.1016/j.trstmh.2005.03.006.
  • Fitzpatrick C, Bangert M, Engels D. Sustainable development goals: diseases that neglect no goals. Nature. 2016;535(7613):493. doi:10.1038/535493c.
  • Bangert M, Molyneux DH, Lindsay SW, Fitzpatrick C, Engels D. The cross-cutting contribution of the end of neglected tropical diseases to the sustainable development goals. Infectious Diseases Poverty. 2017;6(1):73. doi:10.1186/s40249-017-0288-0.
  • Porco TC, Gebre T, Ayele B, et al. Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: A randomized trial. Jama. 2009;302(9):962–968. doi:10.1001/jama.2009.1266.
  • Keenan JD, Ayele B, Gebre T, et al. Childhood mortality in a cohort treated with mass azithromycin for trachoma. Clin Infect Dis. 2011;52(7):883–888. doi:10.1093/cid/cir069.
  • Coles CL, Levens J, Seidman JC, Mkocha H, Munoz B, West S. Mass distribution of azithromycin for trachoma control is associated with short-term reduction in risk of acute lower respiratory infection in young children. Pediatr Infect Dis J. 2012;31(4):341–346. doi:10.1097/INF.0b013e31824155c9.
  • Marks M, Bottomley C, Tome H, et al. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital chlamydia trachomatis infection in the Solomon Islands. Sex Transm Infect. 2016;92:261–265. doi:10.1136/sextrans-2015-052439.
  • Oswald WE, Stewart AE, Kramer MR, et al. Active trachoma and community use of sanitation, Ethiopia. Bull World Health Organ. 2017;95(4):250–260. doi:10.2471/BLT.16.177758.
  • Garn JV, Boisson S, Willis R, et al. Sanitation and water supply coverage thresholds associated with active trachoma: modeling cross-sectional data from 13 countries. PLoS Negl Trop Dis. 2018;12(1):e0006110. doi:10.1371/journal.pntd.0006110.